Carlo BONFANTI

Dr. Carlo BONFANTI

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Stefano PorruStefano Porru
Stefano Porru
Maria Grazia Lourdes MonacoMaria Grazia Lourdes Monaco
Maria Grazia Lourdes Monaco
GSGianluca Spiteri
Gianluca Spiteri
Angela CartaAngela Carta
Angela Carta
MPMaria Diletta Pezzani
Maria Diletta Pezzani
GVGiuseppe Verlato
Giuseppe Verlato
Background: The research aimed to investigate the incidence of SARS-CoV-2 breakthrough infections and their determinants in a large European cohort of more than 60,000 health workers. Methods: A multicentric retrospective cohort study, involving 12 European centers, was carried out within the ORCHESTRA project, collecting data up to 18 November 2021 on fully vaccinated health workers. The cumulative incidence of SARS-CoV-2 breakthrough infections was investigated with its association with occupational and social–demographic characteristics (age, sex, job title, previous SARS-CoV-2 infection, antibody titer levels, and time from the vaccination course completion). Results: Among 64,172 health workers from 12 European health centers, 797 breakthrough infections were observed (cumulative incidence of 1.2%). The primary analysis using individual data on 8 out of 12 centers showed that age and previous infection significantly modified breakthrough infection rates. In the meta-analysis of aggregated data from all centers, previous SARS-CoV-2 infection and the standardized antibody titer were inversely related to the risk of breakthrough infection (p = 0.008 and p = 0.007, respectively). Conclusion: The inverse correlation of antibody titer with the risk of breakthrough infection supports the evidence that vaccination plays a primary role in infection prevention, especially in health workers. Cellular immunity, previous clinical conditions, and vaccination timing should be further investigated.

1 January 2004 in Peptide Science
Verified
Journal Article
Closed access
PDF file
SFSimona Fiorentini
Simona Fiorentini
EMElena Marini
Elena Marini
LBLuisa Bozzo
Luisa Bozzo
LTLaura Trainini
Laura Trainini
LSLamiaa Saadoune
Lamiaa Saadoune
ACArnaldo Caruso
Arnaldo Caruso

25 October 2012 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
MFMassimo Franchini
Massimo Franchini
CRChiara Rossi
Chiara Rossi
CMCarlo Mengoli
Carlo Mengoli
Francesco FrattiniFrancesco Frattini
Francesco Frattini
SCSilvia Crestani
Silvia Crestani
CBCarlo BONFANTI
Carlo BONFANTI

25 February 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
ACAgnese Comelli
Agnese Comelli
EFEmanuele Focà
Emanuele Focà
ESEmanuele Sansone
Emanuele Sansone
CTcesare tomasi
cesare tomasi
EAElisa Albini
Elisa Albini
Francesco CastelliFrancesco Castelli
Francesco Castelli
Background: COVID-19 pandemic is requesting unprecedented efforts by health-care workers (HCWs) in all countries, and especially in Italy during the first semester of 2020. Methods: This is a retrospective, observational study conducted at the Spedali Civili General Hospital, in Brescia, Northern Italy during the SARS CoV-2 pandemic in the first semester of 2020. Serum samples from HCWs were tested for SARS-CoV-2 spike protein-specific antibodies. An online survey was used to collect demographic, clinical, and epidemiological data. Results: Of the 1893 HCWs included, 433 (22.9%) were found seropositive for SARS-CoV-2 IgG. The cumulative prevalence of SARS-CoV-2 infection (antibodies production or past positive RT-PCR on nasal/throat swab) was 25.1% (475/1893). Fifty-six out of 433 (13%) seropositive participants declared to have been asymptomatic during the study period. The development of COVID-19 signs or symptoms is the main determinant of seropositivity (OR: 11.3, p < 0.0001) along with their duration and severity. 40/290 (14.5%) HCWs with documented positive RT-PCR during the study period did not show any detectable antibody response. IgG levels positively correlate with age, COVID-19-compatible signs and symptoms experienced and their duration. Conclusions: In this study, carried out in one of the most affected areas in Europe, we demonstrate that most HCWs with COVID-19 related symptoms develop a spike protein-specific antibodies with potential neutralizing effect.

1 February 1992 in Journal of Interferon Research
Verified
Journal Article
Closed access
ACArnaldo Caruso
Arnaldo Caruso
EVElisabetta Viani
Elisabetta Viani
LTLaura Tiberio
Laura Tiberio
PPPatrizia Pollara
Patrizia Pollara
EMEugenio Monti
Eugenio Monti
ATAdolfo Turano
Adolfo Turano
To study the domain(s) responsible for the different biological activities of human interferon-γ (HuIFN-γ), rabbits were immunized with peptides corresponding to the five most hydrophilic amino acid sequences of the lymphokine. The resulting antisera were able to recognize both the immunizing peptide and the native protein. Antibodies to the carboxy-terminal region (amino acids 125–137) of HuIFN-γ were able to interfere with the immunomodulating, antiviral, and antiproliferative activities of the lymphokine. Inhibition of the antiproliferative and antiviral activity was also observed using antibodies raised against the amino-terminal region (amino acids 4–16) and amino acids 80–95, respectively, but to a lesser extent than that observed with antibodies to the carboxyl terminus. The capability of these antibody preparations to partially interfere with only one of the lymphokine's biological activities might be explained by a mechanism of steric hindrance. The use of polyclonal antibodies allowed us to limit the presence of epitopes responsible for recombinant (r)HuIFN-γ biological activities to the carboxy-terminal region.

29 February 2016 in BMC Public Health
Verified
Journal Article
Open access
PDF file
(G(on behalf of the Clamigon Study Group)
(on behalf of the Clamigon Study Group)
Alberto Matteelli MatteelliAlberto Matteelli Matteelli
Alberto Matteelli Matteelli
MCMichela Capelli
Michela Capelli
GSGiorgia Sulis
Giorgia Sulis
GTGiuseppe Toninelli
Giuseppe Toninelli
FDFrancesco Donato
Francesco Donato
We carried out a study to evaluate the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae genital infections in school-based adolescents in Northern Italy. Systematic screening for C. trachomatis and N. gonorrhoeae genital infection was performed in 13th grade students in the province of Brescia, an industrialized area in Northern Italy. Student filled in a questionnaire on sexual behaviour and provided a urine sample for microbiological testing. A total of 2,718 students (mean age: 18.4 years; 59.1 % females) provided complete data (62.2 % of those eligible). Overall 2,059 students (75.8 %) were sexually active (i.e. had had at least one partner), and the mean age at sexual debut was 16.1 years (SD: 1.4). Only 27.5 % of the sexually active students reported regular condom use during the previous 6 months, with higher frequency in males than in females (33.8 % vs 24.2 %). No case of N. gonorrhoeae infection was detected, while C. trachomatis was found in 36 adolescents, with a prevalence of 1.7 % (95 % CI: 1.2–2.4) among sexually active students, and no statistical difference between females and males (1.9 and 1.4 %, respectively). Inconsistent condom use (odds ratio, OR = 5.5) and having had more than one sexual partner during the previous 6 months (OR = 6.8) were associated with an increased risk of Chlamydia infection at multivariate analysis. The prevalence of C. trachomatis infection among sexually active adolescents in Northern Italy was low, despite a high proportion of students who engage in risky sexual behaviour. No cases of N. gonorrhoeae infection were identified.